1. Home
  2. RNXT vs BWEN Comparison

RNXT vs BWEN Comparison

Compare RNXT & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • BWEN
  • Stock Information
  • Founded
  • RNXT 2012
  • BWEN N/A
  • Country
  • RNXT United States
  • BWEN United States
  • Employees
  • RNXT N/A
  • BWEN N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • RNXT Health Care
  • BWEN Industrials
  • Exchange
  • RNXT Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • RNXT 44.6M
  • BWEN 42.7M
  • IPO Year
  • RNXT 2021
  • BWEN N/A
  • Fundamental
  • Price
  • RNXT $1.14
  • BWEN $2.38
  • Analyst Decision
  • RNXT Strong Buy
  • BWEN Strong Buy
  • Analyst Count
  • RNXT 2
  • BWEN 3
  • Target Price
  • RNXT $7.25
  • BWEN $4.50
  • AVG Volume (30 Days)
  • RNXT 107.8K
  • BWEN 390.6K
  • Earning Date
  • RNXT 08-14-2025
  • BWEN 08-12-2025
  • Dividend Yield
  • RNXT N/A
  • BWEN N/A
  • EPS Growth
  • RNXT N/A
  • BWEN N/A
  • EPS
  • RNXT N/A
  • BWEN N/A
  • Revenue
  • RNXT $240,000.00
  • BWEN $142,358,000.00
  • Revenue This Year
  • RNXT $3,104.65
  • BWEN $7.86
  • Revenue Next Year
  • RNXT $301.89
  • BWEN $4.51
  • P/E Ratio
  • RNXT N/A
  • BWEN N/A
  • Revenue Growth
  • RNXT N/A
  • BWEN N/A
  • 52 Week Low
  • RNXT $0.75
  • BWEN $1.41
  • 52 Week High
  • RNXT $1.69
  • BWEN $3.03
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 33.69
  • BWEN 48.83
  • Support Level
  • RNXT $1.23
  • BWEN $2.46
  • Resistance Level
  • RNXT $1.28
  • BWEN $2.85
  • Average True Range (ATR)
  • RNXT 0.06
  • BWEN 0.22
  • MACD
  • RNXT -0.01
  • BWEN -0.04
  • Stochastic Oscillator
  • RNXT 15.00
  • BWEN 8.45

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

Share on Social Networks: